I-ACT FOR CHILDREN TO CO-HOST DUCHENNE MUSCULAR DYSTROPHY PLATFORM TRIAL STAKEHOLDER MEETING

By Stephen Mcconoughey | September 3, 2019 | Comments Off on I-ACT FOR CHILDREN TO CO-HOST DUCHENNE MUSCULAR DYSTROPHY PLATFORM TRIAL STAKEHOLDER MEETING

SHERATON SILVER SPRING | SILVER SPRING, MD SEPTEMBER 9, 2019 | 8:30 AM-4:30 PM I-ACT for Children will co-host the first Duchenne Muscular Dystrophy Platform Trial Community Meeting on Sept. 9 with collaborators Parent Project Muscular Dystrophy and the Critical Path Institute. The Duchenne Platform Trial is being designed to increase access to therapeutic trials…

I-ACT for Children Selects Advarra as Central IRB for its Pediatric Clinical Trials Site Network

By Stephen Mcconoughey | June 10, 2019 | Comments Off on I-ACT for Children Selects Advarra as Central IRB for its Pediatric Clinical Trials Site Network

I-ACT for Children has selected Advarra as the central IRB for the I-ACT for Children Clinical Trials Site Network – a geographically and therapeutically diverse network of pediatric trial sites committed to improving efficiencies and capabilities for the conduct of clinical trials. I-ACT for Children launched the central IRB function to streamline processes, expedite IRB…

Chiesi Group Joins I-ACT for Children as an Annual Member

By Stephen Mcconoughey | April 24, 2019 | Comments Off on Chiesi Group Joins I-ACT for Children as an Annual Member

Today I-ACT for Children welcomes Chiesi Group as our newest Annual Member. Click on the link below for more details. Full press release

Bayer Joins I-ACT for Children as an Annual Member

By Stephen Mcconoughey | April 15, 2019 | Comments Off on Bayer Joins I-ACT for Children as an Annual Member

We are thrilled to welcome Bayer AG as I-ACT for Children’s newest Annual Member! Click on the image below to read the full announcement.

Eli Lilly and Company Joins I-ACT for Children as a Sustaining Member

By Stephen Mcconoughey | March 19, 2019 | Comments Off on Eli Lilly and Company Joins I-ACT for Children as a Sustaining Member

We are delighted to announce that Eli Lilly and Company has joined I-ACT for Children as our newest Sustaining Member. Please click the image below for the press release and full details.

Dr. Rosenberg will Co-lead a Workshop at the International Meeting on Simulation in Healthcare

By Stephen Mcconoughey | January 25, 2019 | Comments Off on Dr. Rosenberg will Co-lead a Workshop at the International Meeting on Simulation in Healthcare

I-ACT for Children’s Dr. Carol Rosenberg (read full bio), Quality Improvement Project Manager, will co-lead a workshop at the International Meeting on Simulation in Healthcare (http://imsh2019.com/) on January 29th.  Dr. Rosenberg will co-lead a workshop with Drs. Jennifer Arnold and Maria Carmen Diaz that focuses on the use of high-fidelity simulators to educate patients and their family…

Novartis Joins I-ACT for Children as a Sustaining Member

By Stephen Mcconoughey | October 12, 2018 | Comments Off on Novartis Joins I-ACT for Children as a Sustaining Member

We are thrilled to welcome Novartis as our newest sustaining member, click the image below to read the full press release.  

I-ACT for Children Staff Honored at SoCRA Annual Meeting

By Stephen Mcconoughey | October 9, 2018 | Comments Off on I-ACT for Children Staff Honored at SoCRA Annual Meeting

At the recent annual meeting of the Society of Clinical Research Associates (SoCRA), I-ACT for Children’s Lisa Benson and Janelle Allen were honored for their contributions to pediatric clinical trials. Lisa Benson, Vice President of Clinical Research Operations, Quality and Education, was awarded the SoCRA President’s Award for Distinguished Service. The award recognized the impact Ms. Benson’s…

Multiple Positions Available at I-ACT for Children

By Stephen Mcconoughey | June 28, 2018 | Comments Off on Multiple Positions Available at I-ACT for Children

As I-ACT for Children continues to grow, we are again in need for talented individuals to join our team. If you are interested in joining a group of hard-working, dedicated individuals focused on improving pediatric healthcare, please review the open positions found below. Medical Director Clinical Project Manager Senior Administrative Assistant   All applications should…

I-ACT for Children Welcomes Laura Gordon as Chief Executive Officer

By Stephen Mcconoughey | April 18, 2018 | Comments Off on I-ACT for Children Welcomes Laura Gordon as Chief Executive Officer

The Institute for Advanced Clinical Trials for Children (I-ACT for Children) is pleased to welcome Laura Gordon as Chief Executive Officer. Ms. Gordon is a highly experienced executive leader with expertise in health policy and communications, organizational development and stakeholder engagement in the public and private healthcare sectors. She most recently was General Manager of…

You can “ACT for Children” by donating to this effort today!

The Institute’s work relies on financial contributions from individuals, groups, institutions and others